• Reversing new-onset typediabetes with py

    From ScienceDaily@1:317/3 to All on Wed Nov 10 21:30:42 2021
    Reversing new-onset typediabetes with pyramid-like DNA: Mouse study


    Date:
    November 10, 2021
    Source:
    American Chemical Society
    Summary:
    Usually diagnosed in children, teens and young adults, type 1
    diabetes is an autoimmune disease in which the immune system attacks
    and destroys insulin-secreting beta-cells in the pancreas. As a
    result, people with type 1 diabetes can't regulate their blood sugar
    levels and require insulin treatment for survival. Now, researchers
    have reversed new-onset type 1 diabetes in mice with pyramid-like
    DNA molecules called tetrahedral framework nucleic acids (tFNAs).



    FULL STORY ========================================================================== Usually diagnosed in children, teens and young adults, type 1 diabetes
    is an autoimmune disease in which the immune system attacks and destroys insulin- secreting b-cells in the pancreas. As a result, people with
    type 1 diabetes can't regulate their blood sugar levels and require
    insulin treatment for survival. Now, researchers reporting in ACS Applied Materials & Interfaces have reversed new-onset type 1 diabetes in mice
    with pyramid-like DNA molecules called tetrahedral framework nucleic acids (tFNAs).


    ========================================================================== About 64,000 people in the U.S. are diagnosed with type 1 diabetes each
    year, according to the Juvenile Diabetes Research Foundation. There is no
    cure for the disease, and to manage symptoms, people must measure their
    blood sugar levels throughout the day and administer insulin through an injection or pump.

    Although scientists still don't know exactly what causes the body to
    turn against itself and attack insulin-secreting cells, people with type
    1 diabetes have fewer regulatory T cells (Tregs) -- immune cells that
    suppress the differentiation and activation of other, self-attacking
    T cells. In a recent study published in ACS' Nano Letters, Yunfeng Lin
    and colleagues showed that treating mice with tFNAs could prevent type
    1 diabetes, in part by increasing Treg numbers. Originally designed to
    carry other therapeutic molecules into cells, tFNAs have recently been
    shown to modulate the immune system on their own. Now, the researchers
    wanted to find out if these molecules could reverse new-onset type 1
    diabetes, before pancreatic b-cells were completely destroyed.

    The researchers made tFNAs from four single-stranded DNA segments that
    self- assembled into pyramid-like shapes, called tetrahedrons. But whereas
    a pyramid is square at its base, tetrahedrons are triangular. Then,
    every other day for 4 weeks, they injected the tFNAs into 10 mice with new-onset type 1 diabetes, while 10 other diabetic mice were injected
    with saline. In the control mice, blood glucose levels continued to
    rise, and 60% of the mice died during the 12- week follow-up period. In contrast, blood glucose levels in mice treated with tFNAs went down
    to normal levels, and none of the rodents died. In a further analysis
    of the tFNA-treated mice, the team found that pancreatic b-cells were protected, and Tregs were restored to normal levels, while auto-reactive
    T cells decreased in the pancreas. Although the findings still need to
    be verified in people, tFNAs are one of the most promising candidates
    for type 1 diabetes immunotherapy, the researchers say.

    ========================================================================== Story Source: Materials provided by American_Chemical_Society. Note:
    Content may be edited for style and length.


    ========================================================================== Journal Reference:
    1. Shaojingya Gao, Mi Zhou, Yanjing Li, Dexuan Xiao, Yun Wang,
    Yangxue Yao,
    Yang Gao, Xiaoxiao Cai, Yunfeng Lin. Tetrahedral Framework Nucleic
    Acids Reverse New-Onset Type 1 Diabetes. ACS Applied Materials &
    Interfaces, 2021; 13 (43): 50802 DOI: 10.1021/acsami.1c16151 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2021/11/211110131653.htm

    --- up 9 weeks, 6 days, 9 hours, 25 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)